BPA Call 36C25219A0002-36C25223N0041

Award Date 10/1/22
Potential Completion Date 2/16/24
Potential Value $42K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) awarded a Firm Fixed Price Delivery Order to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, for the provision of a MULTIPLEX PCE FILM ARRAY 2.0 system. The $110,396.98 award is funded through the VA's Veterans Integrated Service Network (VISN) 8. Biofire Diagnostics LLC holds a General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests, which was...
This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract, valued at $79,037.70, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to provide in-vitro reagents. The contract is a Blanket Purchase Agreement (BPA) call order under Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The...
Biofire Diagnostics LLC has been awarded a firm fixed price blanket purchase agreement by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to provide laboratory tests and support from October 2021 through November 2023. The potential value of this contract is $134,280. Biofire Diagnostics LLC is a prime contractor that specializes in syndromic infectious disease testing. They will leverage their existing General Services Administration...
Biofire Diagnostics LLC was awarded a blanket purchase agreement (BPA) call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17. The contract has a potential value of $156,971.13 to provide laboratory supplies for use with Biofire's proprietary equipment through July 25, 2023. No set-aside designation was used. The award was issued against Biofire's General Services Administration Federal Supply Schedule contract for in vitro...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization, to provide BIOFIRE FILM ARRAY SUPPLIES. The contract was awarded against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The potential value of the contract is $478,618.32, and it does not have a set-aside...
This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract, valued at $798,120.00, is for MOLECULAR PATHOGEN DETECTION services and was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) through its Veterans Integrated Service Network (VISN) 8. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply...
This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The award, valued at $1,598,542.00, is for molecular pathogen detection products and services. The contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its Veterans Integrated Service Network (VISN) 8. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration...
This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services. The contract, valued at $810,091.80, was awarded by the Veterans Health Administration (VHA) of the Department of Veterans Affairs (VA) under the VA's Veterans Integrated Service Network (VISN) 8. The contract is a BPA (Blanket Purchase Agreement) call against Biofire's General Services Administration (GSA) Federal Supply...
This federal contract award was made by the Veterans Integrated Service Network (VISN) 23 of the Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $92,880 Firm Fixed Price contract is a Blanket Purchase Agreement (BPA) call order under Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract is for the provision of virus,...
This is a federal contract award to Biofire Diagnostics LLC, a for-profit, foreign-owned biotech company, to provide reagents for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is a $36,451.72 delivery order placed against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The contract has a completion date of September 30, 2022 and does not utilize any set-aside...

Biofire Diagnostics LLC has been awarded a firm fixed price contract valued at $41,705.70 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. This call order was placed against Biofire's existing General Services Administration Federal Supply Schedule contract for invitro diagnostics, reagents, and tests to acquire reagents for multiplex polymerase chain reaction pathogen detection. Biofire Diagnostics LLC is a leading provider of syndromic infectious disease testing products and services to federal agencies such as the Department of Veterans Affairs and Defense Health Agency. No set-aside designation was used for this award to supply critical diagnostic capabilities in support of the VA's healthcare mission.

Generated 2/18/24, 12:24 AM